Redcare Pharmacy stock traded at EUR 132 per share at the end 2024 translating into a market capitalization of USD 2,740 mil.
Since the end of 2019, stock has appreciated by 203% representing an annual average growth of 24.8%. In absolute terms, the value of the company rose by USD 2 mil.
At the end of 2024, the firm traded at price to earnings of -58.0x. Over the last five years, this multiple achieved a high of -10.2x in 2022 and a low of -180x in 2023 with an average of -78.2x.
In terms of EV/EBITDA, stock traded at 88.6x at the end of 2024. Since 2019, stock has traded between -50.0x and 127x with an average of 40.8x.
You can see all the company’s data at Redcare Pharmacy profile, or you can download a report on the company in the report section.
Helgi Library 
